HAVCR2 and cancer: Unlike the results observed in infections and cancer (19), the combinations of blocking Tim-3 and PD-1 resulted in a profound reduction in Ki67 expression (Figure 4A) and the activation (Figure 4B) of CD4+T cells in LEASO.